La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
West Pharmaceutical Services Gestione
Gestione criteri di controllo 4/4
West Pharmaceutical Services' Il CEO è Eric Green, nominato in Apr2015, e ha un mandato di 9.33 anni. la retribuzione annua totale è $ 9.40M, composta da 12.1% di stipendio e 87.9% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.23% delle azioni della società, per un valore di $ 50.44M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 4.8 anni e 9.3 anni.
Informazioni chiave
Eric Green
Amministratore delegato
US$9.4m
Compenso totale
| Percentuale dello stipendio del CEO | 12.1% |
| Mandato del CEO | 9.3yrs |
| Proprietà del CEO | 0.2% |
| Durata media del management | 4.8yrs |
| Durata media del Consiglio di amministrazione | 9.3yrs |
Aggiornamenti recenti sulla gestione
Recent updates
West Pharmaceutical Services, Inc. Just Missed Earnings - But Analysts Have Updated Their Models
Jul 28
West Pharmaceutical: Continued Destocking And A High Valuation Post Q2 Results (Rating Maintained)
Jul 25Is It Time To Consider Buying West Pharmaceutical Services, Inc. (NYSE:WST)?
Jul 15We Think West Pharmaceutical Services (NYSE:WST) Can Stay On Top Of Its Debt
Jun 27Estimating The Fair Value Of West Pharmaceutical Services, Inc. (NYSE:WST)
May 21West Pharmaceutical: Pick And Shovels Of The Injectable Drug Industry
May 11West Pharmaceutical Services, Inc.'s (NYSE:WST) Business Is Yet to Catch Up With Its Share Price
Mar 30Is West Pharmaceutical Services (NYSE:WST) A Risky Investment?
Mar 12Why West Pharma Is Far From Done
Feb 28West Pharmaceutical Services, Inc.'s (NYSE:WST) Intrinsic Value Is Potentially 19% Below Its Share Price
Feb 20West Pharmaceutical Services: Still Too Expensive After The Recent Drop
Feb 20What Does West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Indicate?
Jan 10West Pharmaceutical: Great Business, Not So Great Valuation
Jan 08What West Pharmaceutical Services, Inc.'s (NYSE:WST) P/E Is Not Telling You
Dec 18West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet
Nov 27West Pharmaceutical Services: The Run Might Be Over
Oct 18Is West Pharmaceutical Services, Inc. (NYSE:WST) Potentially Undervalued?
Sep 24Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?
Aug 22West Pharmaceutical: Revise To Buy On Exceptional Economic Characteristics
Aug 08What Is West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Doing?
Jun 26West Pharmaceutical: Hard To Justify The Price
May 26Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?
May 16At US$330, Is It Time To Put West Pharmaceutical Services, Inc. (NYSE:WST) On Your Watch List?
Mar 20West Pharmaceutical Services' (NYSE:WST) Soft Earnings Don't Show The Whole Picture
Feb 28West Pharmaceutical Q4 2022 Earnings Preview
Feb 15West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet
Jan 31West Pharmaceutical: An Earnings Decline Seen In 2023, Shares Still Appear Expensive
Dec 19West Pharmaceutical declares $0.19 dividend
Dec 13Why West Pharmaceutical Services, Inc. (NYSE:WST) Could Be Worth Watching
Nov 29West Pharmaceutical Q3 2022 Earnings Preview
Oct 26West Pharmaceutical Services (NYSE:WST) Seems To Use Debt Rather Sparingly
Oct 25West Pharmaceutical Services: Shares Need To Get Cheaper To Make Sense
Oct 02Is West Pharmaceutical Services, Inc. (NYSE:WST) Expensive For A Reason? A Look At Its Intrinsic Value
Sep 14Is There Now An Opportunity In West Pharmaceutical Services, Inc. (NYSE:WST)?
Aug 31Do West Pharmaceutical Services' (NYSE:WST) Earnings Warrant Your Attention?
Aug 18Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$525m |
| Mar 31 2024 | n/a | n/a | US$569m |
| Dec 31 2023 | US$9m | US$1m | US$593m |
| Sep 30 2023 | n/a | n/a | US$559m |
| Jun 30 2023 | n/a | n/a | US$519m |
| Mar 31 2023 | n/a | n/a | US$552m |
| Dec 31 2022 | US$8m | US$1m | US$586m |
| Sep 30 2022 | n/a | n/a | US$631m |
| Jun 30 2022 | n/a | n/a | US$686m |
| Mar 31 2022 | n/a | n/a | US$684m |
| Dec 31 2021 | US$9m | US$1m | US$662m |
| Sep 30 2021 | n/a | n/a | US$613m |
| Jun 30 2021 | n/a | n/a | US$519m |
| Mar 31 2021 | n/a | n/a | US$423m |
| Dec 31 2020 | US$8m | US$989k | US$346m |
| Sep 30 2020 | n/a | n/a | US$312m |
| Jun 30 2020 | n/a | n/a | US$286m |
| Mar 31 2020 | n/a | n/a | US$261m |
| Dec 31 2019 | US$7m | US$936k | US$242m |
| Sep 30 2019 | n/a | n/a | US$230m |
| Jun 30 2019 | n/a | n/a | US$229m |
| Mar 31 2019 | n/a | n/a | US$219m |
| Dec 31 2018 | US$5m | US$880k | US$207m |
| Sep 30 2018 | n/a | n/a | US$155m |
| Jun 30 2018 | n/a | n/a | US$151m |
| Mar 31 2018 | n/a | n/a | US$133m |
| Dec 31 2017 | US$5m | US$824k | US$151m |
Compensazione vs Mercato: La retribuzione totale di Eric ($USD 9.40M ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 13.21M ).
Compensazione vs guadagni: La retribuzione di Eric è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Eric Green (54 yo)
9.3yrs
Mandato
US$9,395,896
Compensazione
Mr. Eric M. Green serves as Independent Director at Ecolab Inc. since December 08, 2022. He has been the Chief Executive Officer of West Pharmaceutical Services, Inc. since April 24, 2015 and its President...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Non-Independent Chair of the Board | 9.3yrs | US$9.40m | 0.23% $ 50.0m | |
| Senior VP & CFO | 6.2yrs | US$3.64m | 0.0095% $ 2.1m | |
| Senior VP & CTO | 3.7yrs | US$1.67m | 0.0039% $ 850.6k | |
| Senior VP | 3.7yrs | US$1.49m | 0.0019% $ 403.7k | |
| Senior VP & Chief Commercial Officer | 4.8yrs | US$1.53m | 0.0067% $ 1.5m | |
| VP, Chief Accounting Officer & Corporate Controller | 4.8yrs | Nessun dato | 0.0018% $ 388.6k | |
| Head of Investor Relations | no data | Nessun dato | Nessun dato | |
| Vice President of Global Communications | no data | Nessun dato | Nessun dato | |
| Senior VP of Strategy & Corporate Development | less than a year | Nessun dato | Nessun dato | |
| Chief Human Resources Officer & Senior VP | 8.8yrs | US$1.14m | 0.0090% $ 1.9m | |
| Senior Vice President of Integrated Systems | 4.8yrs | Nessun dato | Nessun dato | |
| Senior VP and Chief Quality & Regulatory Officer | 2.3yrs | Nessun dato | Nessun dato |
4.8yrs
Durata media
54.5yo
Età media
Gestione esperta: Il team dirigenziale di WST è considerato esperto (durata media dell'incarico 4.8 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Non-Independent Chair of the Board | 9.3yrs | US$9.40m | 0.23% $ 50.0m | |
| Independent Director | 10.5yrs | US$359.35k | 0.024% $ 5.1m | |
| Independent Director | 4.5yrs | US$330.66k | 0.0034% $ 723.2k | |
| Independent Director | 16.8yrs | US$390.35k | 0.059% $ 12.8m | |
| Independent Director | 13.5yrs | US$378.23k | 0.056% $ 12.1m | |
| Independent Director | 13.5yrs | US$377.01k | 0.059% $ 12.8m | |
| Lead Independent Director | 7.9yrs | US$367.44k | 0.012% $ 2.6m | |
| Independent Director | 2.1yrs | US$331.46k | 0.0015% $ 319.5k | |
| Independent Director | 12.5yrs | US$362.83k | 0.040% $ 8.7m | |
| Independent Director | 7.2yrs | US$333.45k | Nessun dato | |
| Honorary Director | no data | Nessun dato | Nessun dato | |
| Independent Director | 3yrs | US$321.43k | 0.00087% $ 187.8k |
9.3yrs
Durata media
63yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di WST sono considerati esperti (durata media dell'incarico 9.3 anni).